ScreenerHero

PANG Pangaea Oncology, S.A.

BME · ES · Healthcare · Diagnostics & Research · panoncology.com
1.430EUR0.00%Mkt Cap: 55.82M $P/E: —

Pangaea Oncology, S.A., a precision oncology company, provides a range of services to cancer patients in Spain and the rest of European Union countries. The company offers molecular diagnostics, including mutation analys…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
DHR
Danaher Corporation
$155.51BUSDP/E 39.4
NTRA
Natera, Inc.
$61.35BUSD
LONN
Lonza Group AG
$45.82BUSDP/E 38.1
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
ILMN
Illumina, Inc.
$44.35BUSDP/E 54.8
IQV
IQVIA Holdings Inc.
$43.80BUSDP/E 33.1
WAT
Waters Corporation
$43.21BUSDP/E 111.4
IDXX
IDEXX Laboratories, Inc.
$41.58BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
GH
Guardant Health, Inc.
$25.12BUSD
LH
Labcorp Holdings Inc.
$25.03BUSDP/E 25.5
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc.
$17.32BUSDP/E 36.4
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ERF
Eurofins Scientific SE
$14.05BUSDP/E 26.2
ICLR
ICON Public Limited Company
$12.99BUSDP/E 177.2
BIM
bioMérieux S.A.
$10.02BUSDP/E 20.0
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2

Key Statistics

Company
Market Cap55.82M USD
Enterprise Value58.45M USD
Revenue (TTM)15.79M USD
Gross Profit15.67M USD
Net Income (TTM)-3.91M USD
Revenue/Share0.40 EUR
Last Price1.430 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees165
CountryES
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)Infinity
PEG—
EV/EBITDA-20.66
EV/Revenue3.70
P/S3.54
P/B2.41
EPS (TTM)-0.11
EPS (Forward)0.00
52W Range
1.4300% of range1.750
52W High1.750 EUR
52W Low1.430 EUR
Profitability
Gross Margin99.28%
Oper. Margin-29.69%
EBITDA Margin-17.92%
Profit Margin-24.76%
ROE-16.88%
ROA-11.20%
Growth
Revenue Growth-5.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.74M USD
CapEx (TTM)513.57K USD
FCF Margin-5.96%
FCF Yield-1.69%
Net Debt1.81M USD
Net Debt/EBITDA-0.64
Balance Sheet
Debt/Equity0.27
Current Ratio1.78
Quick Ratio1.47
Book Value/Sh0.59 EUR
Cash/Share0.09 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.35.91M
Float10.87M
Insiders69.26%
Institutions0.34%
Technical
SMA 501.510 (-5.3%)
SMA 2001.601 (-10.7%)
Beta0.01
S&P 52W Chg14.58%
Avg Vol (30d)170
Avg Vol (10d)0
Technical Indicators
RSI (14)18.3
MACD-0.0282
MACD Signal-0.0282
MACD Hist.+0.0000
BB Upper1.559 EUR
BB Middle1.463 EUR
BB Lower1.367 EUR
BB Width13.19%
ATR (14)0.0056 EUR
Vol Ratio (20d)0.00x